WT1 and hematologic disorder: It must be noted, however, that when assessing all hematological malignancies together, hypermethylation of the AWT1 promoter it does not perform well as a diagnostic factor for unspecified leukemias/lymphomas (sensitivity 47%; specificity 100%; PPV 100%; NPV 43.6%) (Additional file 2: Table S3).